Two recent PA Breast Cancer Coalition Potamkin Prize winners are behind new, innovative metastatic breast cancer clinical trials funded for the next six years.
Dr. Eric Winer of Yale Cancer Center and Dr. Antonio Wolff of Johns Hopkins Sidney Kimmel Cancer Center (pictured left) serve as principal investigators of the trials, which will be conducted across 15 institutions in the United States. The goal is to create personalized treatments for patients facing stage IV breast cancer using blood samples, tumor biopsies, high-resolution imaging, and medical records to monitor each patient’s cancer in near real-time. This will allow oncologists and researchers to modify treatment plans as soon as possible if the cancer is not responding.
The trials, which begin in 2026, are a product of the opens in a new windowTranslational Breast Cancer Research Consortium, which was co-founded by Dr. Wolff who now serves as Chief Operating Officer.
To learn more, opens in a new windowclick here.
